United Therapeutics Corporation News Releases https://ir.unither.com/ United Therapeutics Corporation News Releases en United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference https://ir.unither.com/news-releases/news-release-details/united-therapeutics-corporation-present-goldman-sachs-40th SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , June 5, 2019 /PRNewswire/ --  United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics , will provide an overview and update on the company's business at Wed, 05 Jun 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25596 United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference https://ir.unither.com/news-releases/news-release-details/united-therapeutics-corporation-present-jefferies-2019-0 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 28, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics , will provide an overview and update on the company's business at the Tue, 28 May 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25571 United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin® https://ir.unither.com/news-releases/news-release-details/united-therapeutics-and-deka-announce-fda-clearance-unity RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H. , May 7, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of 510(k) clearance by the U.S. Food and Drug Administration ( FDA ) for the Unity Subcutaneous Delivery Tue, 07 May 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25546 United Therapeutics Corporation Reports First Quarter 2019 Financial Results https://ir.unither.com/news-releases/news-release-details/united-therapeutics-corporation-reports-first-quarter-2019 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , May 1, 2019 /PRNewswire/ --  United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31, 2019. "I'm very pleased to report that last quarter we helped more pulmonary arterial hypertension Wed, 01 May 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25521 United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services https://ir.unither.com/news-releases/news-release-details/united-therapeutics-announces-fda-approval-xpstm-and-steen SILVER SPRING, Md. , April 29, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc. , a subsidiary of XVIVO Perfusion AB (STO: XVIVO), has received Premarket Approval (PMA) from the U.S. Mon, 29 Apr 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25481 United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019 https://ir.unither.com/news-releases/news-release-details/united-therapeutics-corporation-report-first-quarter-2019 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , April 24, 2019 /PRNewswire/ --  United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2019 financial results before the market opens on Wednesday, May 1, 2019 . Wed, 24 Apr 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25471 United Therapeutics Issues Statement In Response To Meritless Lawsuit https://ir.unither.com/news-releases/news-release-details/united-therapeutics-issues-statement-response-meritless-lawsuit SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , April 17, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) was named as a defendant, along with Smiths Medical ASD, Inc. , in a lawsuit filed in federal court by Sandoz Inc. and RareGen, LLC on April 16, 2019 . Wed, 17 Apr 2019 22:52:00 -0400 United Therapeutics Corporation News Releases 25466 United Therapeutics Announces BEAT Study of Esuberaprost Does Not Meet Primary Endpoint https://ir.unither.com/news-releases/news-release-details/united-therapeutics-announces-beat-study-esuberaprost-does-not SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , April 8, 2019 /PRNewswire/ --  United Therapeutics Corporation (Nasdaq: UTHR) today announced that the BEAT clinical study of esuberaprost tablets in patients suffering from pulmonary arterial hypertension did not meet its primary endpoint of Mon, 08 Apr 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25446 United Therapeutics Corporation to Present at Oppenheimer 29th Annual Healthcare Conference https://ir.unither.com/news-releases/news-release-details/united-therapeutics-corporation-present-oppenheimer-29th-annual SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , March 12, 2019 /PRNewswire/ --  United Therapeutics Corporation (Nasdaq: UTHR) announced today that Martine Rothblatt , Ph.D., Chairman and Chief Executive Officer of United Therapeutics , will provide an overview and update on the company's Tue, 12 Mar 2019 06:00:00 -0400 United Therapeutics Corporation News Releases 25371 United Therapeutics Corporation To Present At Cowen And Company 39th Annual Health Care Conference https://ir.unither.com/news-releases/news-release-details/united-therapeutics-corporation-present-cowen-and-company-39th SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , March 4, 2019 /PRNewswire/ --  United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond , Chief Financial Officer and Treasurer of United Therapeutics , will provide an overview and update on the company's business at Mon, 04 Mar 2019 06:00:00 -0500 United Therapeutics Corporation News Releases 25341